Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Ee Gabison"'
Publikováno v:
(92)2014; EVER 2014-European Association for Vision and Eye Research Conference 2014, Nice, FRA, 2014-10-01-2014-10-04, 199
EVER 2014-European Association for Vision and Eye Research Conference 2014
EVER 2014-European Association for Vision and Eye Research Conference 2014, Oct 2014, Nice, France. WILEY-BLACKWELL, Acta Ophthalmologica, 92, pp.3, 2014, ⟨10.1111/j.1755-3768.2014.T064.x⟩
EVER 2014-European Association for Vision and Eye Research Conference 2014
EVER 2014-European Association for Vision and Eye Research Conference 2014, Oct 2014, Nice, France. WILEY-BLACKWELL, Acta Ophthalmologica, 92, pp.3, 2014, ⟨10.1111/j.1755-3768.2014.T064.x⟩
Purpose Conventional treatments of infections by Herpes simplex virus type 1 (HSV1) do not reduce the burden of latent virus and the resulting risk of viral reactivation. Specific endonucleases (such as meganucleases) could be a tool to reduce relaps
Autor:
M Gailledrat, Marc Labetoulle, Nicolas Huot, Antoine Rousseau, Ee Gabison, Ayla Ergani, Benoit Chapellier
Publikováno v:
Acta Ophthalmologica. 90
Purpose Current anti-viral treatments of Herpes simplex virus type 1 (HSV1) inhibit the viral replication but do not impair the latent form of the virus. This could be addressed by rare cutting endonucleases, such as meganucleases. The aim of this st
Autor:
Ayla Ergani, Antoine Rousseau, Carole Desseaux, Benoit Chapellier, M Gailledrat, Pierre Roy, Marc Labetoulle, Ee Gabison, M Corral
Publikováno v:
Acta Ophthalmologica. 90
Purpose Recombinant Adeno-Associated virus (rAVV) encoding meganucleases specifically designed to address Herpes simplex virus type 1 (HSV1) reduce HSV1 replication both in vitro and ex-vivo. The main issue of this potential antiviral treatment is th
Publikováno v:
Acta Ophthalmologica. 90
Purpose The aim of this study is to assess the antiviral property of a meganuclease targeting HSV-1 in the prevention of HSV endothelitis in a newly develloped rabbit in vivo model. Methods NZW received intracamerular injection of recombinant adeno-a
Publikováno v:
Acta Ophthalmologica. 89
Purpose Despite advances in antiviral therapies, past history of HSV keratitis is associated with poor prognosis of subsequent penetrating keratoplasty.The aim of this study is to assess the antiviral property of a meganuclease targeting HSV in the p
Autor:
Ee Gabison
Publikováno v:
Acta Ophthalmologica. 89
Purpose The aim of this instruction course is to present the medical and surgical management of chronic corneal melts. Methods Interactive clinical cases. Results Modulation of epithelial wound healing using different technics such as epihelial debri
Publikováno v:
Acta Ophthalmologica. 89
Purpose Several studies, using limbal stem cells or mesenchymal stem cells (MCSs), have confirmed the usefulness of these cells to repair epithelial and stromal corneal tissue. However the reparation process might be hampered by a strong inflammatory
Autor:
Stephanie Grosse, Ee Gabison, Julianne Smith, Sylvain Arnould, Nicolas Huot, Frédéric Cédrone, Sébastien Barradeau, Charlotte Mahiet, Carole Desseaux, Marc Labetoulle, Ayla Ergani, Frédéric Paques, Bc Chapellier
Publikováno v:
Acta Ophthalmologica. 89
Purpose Current anti-viral treatments of Herpes simplex virus type 1 (HSV1) inhibit the viral replication but impair neither the viral cycle at its early stages nor the latent form of the virus. Latent HSV1 virus could be addressed by rare cutting en
Autor:
Gabison EE; Service d'Ophtalmologie, Hôpital Fondation Rothschild, Paris, France. Electronic address: egabison@for.paris., Rousseau A; Department of Ophthalmology, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, Centre de Référence Maladies Rares en Ophtalmologie (OPHTARA), Le Kremlin-Bicêtre, France; Ophthalmology Department III, Hôpital des Quinze-Vingts, Paris, France; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Labetoulle M; Department of Ophthalmology, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, Centre de Référence Maladies Rares en Ophtalmologie (OPHTARA), Le Kremlin-Bicêtre, France; Ophthalmology Department III, Hôpital des Quinze-Vingts, Paris, France; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Gazzah A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Villejuif, France., Besse B; Paris-Saclay University, Cancer Medicine Department, Gustave Roussy, Villejuif, France.
Publikováno v:
Progress in retinal and eye research [Prog Retin Eye Res] 2024 Sep 18; Vol. 103, pp. 101302. Date of Electronic Publication: 2024 Sep 18.
Autor:
Hallali G; Ophthalmology Department, Rothschild Foundation Hospital, Paris, France., Guindolet D; Ophthalmology Department, Rothschild Foundation Hospital, Paris, France., Gabison EE; Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.; Ophthalmology Department, Bichat Claude-Bernard Hospital, Paris, France ; and.; Université Paris Cité, Paris, France ., Cochereau I; Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.; Ophthalmology Department, Bichat Claude-Bernard Hospital, Paris, France ; and.; Université Paris Cité, Paris, France ., Doan S; Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.; Ophthalmology Department, Bichat Claude-Bernard Hospital, Paris, France ; and.
Publikováno v:
Cornea [Cornea] 2024 Jul 01; Vol. 43 (7), pp. 890-894. Date of Electronic Publication: 2024 Jan 30.